Ray Dalio’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.3M Buy
+34,390
New +$15.3M 0.06% 212
2025
Q1
Sell
-710
Closed -$286K 806
2024
Q4
$286K Sell
710
-2,742
-79% -$1.1M ﹤0.01% 634
2024
Q3
$1.61M Sell
3,452
-29,777
-90% -$13.8M 0.01% 542
2024
Q2
$15.6M Sell
33,229
-101,466
-75% -$47.6M 0.08% 187
2024
Q1
$56.3M Buy
134,695
+2,341
+2% +$979K 0.28% 69
2023
Q4
$53.9M Sell
132,354
-25,995
-16% -$10.6M 0.3% 65
2023
Q3
$55.1M Sell
158,349
-17,964
-10% -$6.25M 0.33% 59
2023
Q2
$62M Sell
176,313
-27,963
-14% -$9.84M 0.38% 54
2023
Q1
$64.4M Buy
204,276
+103,457
+103% +$32.6M 0.39% 55
2022
Q4
$29.1M Sell
100,819
-63,172
-39% -$18.2M 0.16% 119
2022
Q3
$47.5M Sell
163,991
-53,161
-24% -$15.4M 0.24% 83
2022
Q2
$61.2M Buy
217,152
+187,000
+620% +$52.7M 0.26% 80
2022
Q1
$7.87M Buy
30,152
+17,735
+143% +$4.63M 0.03% 352
2021
Q4
$2.73M Sell
12,417
-2,700
-18% -$593K 0.02% 420
2021
Q3
$2.74M Sell
15,117
-8,139
-35% -$1.48M 0.02% 387
2021
Q2
$4.69M Buy
23,256
+1,567
+7% +$316K 0.03% 341
2021
Q1
$4.66M Buy
21,689
+18,059
+497% +$3.88M 0.04% 228
2020
Q4
$858K Buy
+3,630
New +$858K 0.01% 405
2019
Q4
Sell
-32,260
Closed -$5.47M 577
2019
Q3
$5.47M Buy
+32,260
New +$5.47M 0.05% 137
2019
Q2
Sell
-21,889
Closed -$4.03M 369
2019
Q1
$4.03M Buy
+21,889
New +$4.03M 0.02% 155
2018
Q3
Sell
-15,509
Closed -$2.64M 487
2018
Q2
$2.64M Buy
+15,509
New +$2.64M 0.03% 181
2017
Q3
Sell
-18,673
Closed -$2.41M 397
2017
Q2
$2.41M Buy
+18,673
New +$2.41M 0.02% 156